Publisher
Springer Science and Business Media LLC
Reference73 articles.
1. Viedma-Rodriguez, R. et al. Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (review). Oncol Rep 32, 3–15,
https://doi.org/10.3892/or.2014.3190
(2014).
2. Gee, J. M. et al. Antihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistance. Horm Mol Biol Clin Investig 5, 67–77, doi:j/hmbci.2011.5.issue-2/hmbci.2011.009/hmbci.2011.009.xml/ (2011).
3. Chang, M. Tamoxifen resistance in breast cancer. Biomol Ther (Seoul) 20, 256–267,
https://doi.org/10.4062/biomolther.2012.20.3.256
(2012).
4. Nardone, A., De Angelis, C., Trivedi, M. V., Osborne, C. K. & Schiff, R. The changing role of ER in endocrine resistance. Breast 24(Suppl 2), S60–66,
https://doi.org/10.1016/j.breast.2015.07.015
(2015).
5. Merenbakh-Lamin, K. et al. D538G mutation in estrogen receptor-alpha: A novel mechanism for acquired endocrine resistance in breast cancer. Cancer Res 73, 6856–6864,
https://doi.org/10.1158/0008-5472.CAN-13-1197
(2013).
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献